(Medical Xpress) -- C. Glenn Begley, formerly head of cancer research at pharmaceutical giant Amgen and Lee M. Ellis a cancer researcher at the University of Texas, have published a paper together in Nature that is sure to ...
Blocking the action of vascular endothelial growth factor (VEGF) with the new anti-VEGF drug aflibercept can curb the development of malignant ascites (excessive fluid in the abdomen), a common and painful complication of ...
Dec 20, 2011
0
0
Findings from preclinical studies in a skin cancer model showed that next-generation BRAF inhibitors used alone, or first-generation BRAF inhibitors used in combination with an epidermal growth factor receptor inhibitor, ...
Nov 13, 2011
0
0
(Medical Xpress) -- Researchers from the Australian Venom Research Unit (AVRU) at the University of Melbourne have collaborated with scientists from the University of Papua New Guinea and the University of Costa Rica, to ...
Jun 30, 2011
0
0
(Medical Xpress) -- A clinical trial for a new technology to diagnose and treat prostate cancer marks the first time Purdue University has directed the entire pathway of a therapeutic product from early research to patient ...
Jun 9, 2011
0
0
Investigators at Nationwide Children's have received a grant from the National Institutes of Health (NIH) to help move a therapy for MPS IIIB that has been shown effective in mice toward clinical trials in humans.
May 25, 2011
0
0
